El Vínculo El Vínculo.
Awarded United Kingdom Services

high-throughput sequencing services

Buyer: CELL THERAPY CATAPULT LIMITED

Published
5 December 2025
Place of performance
UK
Procedure
Open procedure
Notice number
080291-2025
Reference
ocds-h6vhtk-058ffe
Official source
Official source

CPV codes

Description

The primary aim of this procurement is to secure a high-throughput sequencing service provider to perform sequencing services for the Cell and Gene Therapy (CGT) Catapult on a fee-per-service basis. This service will support the CGT Catapult's mission of accelerating the commercialization of innovation from research and overcoming technical barriers in advanced therapy medicinal product (ATMP) development. The selected provider's services will complement CGT Catapult's unique technical facilities and expertise at its London site. This procurement seeks comprehensive high-throughput sequencing services. These services will be utilized for deep process characterization, particularly for processes like stem cell differentiation and viral vector manufacturing. The required services include, but are not limited to: Lot 1 - High-throughput short-read sequencing of libraries generated by CGT Catapult (i.e., sequencing only) Lot 2 - Bulk RNA sequencing Lot 3 - Bulk small RNA sequencing Lot 4 - Single-cell RNA sequencing (scRNA-seq) of cryopreserved/fixed samples Lot 5 - AAV genome short-read sequencing Lot 6 - Sanger sequencing

Lots (6)

LotDescriptionCPV codeAmount
1 Lot 1 73110000 Research services —
2 Lot 2
UK
73100000 Research and experimental development services —
3 Lot 3
UK
73100000 Research and experimental development services —
4 Lot 4
UK
73100000 Research and experimental development services —
5 Lot 5
UK
73100000 Research and experimental development services —
6 Lot 6
UK
73100000 Research and experimental development services —

Awards

Awarded toAmountDate
Genewiz UK Ltd — 5 December 2025
Genewiz UK Ltd — 5 December 2025
Genewiz UK Ltd — 5 December 2025
Edinburgh Genetics Limited — 5 December 2025
NOVOGENE (UK) COMPANY LIMITED — 5 December 2025
Biomarker Technologies (BMK) GmbH — 5 December 2025

Official publications

Other tenders from CELL THERAPY CATAPULT LIMITED

See all →

Frequently asked questions

Who is the buyer of this tender?
The contracting authority is CELL THERAPY CATAPULT LIMITED (United Kingdom).
How can I bid for public tenders in the United Kingdom?
Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.